Financial statements Biosynthesis
Balance sheet of Biosynthesis
Company age:
Age:
11 y. 11 m. 9 d.
Share capital:
Share capital:
100 000 PLN
Balance sheet data of BIOSYNTHESIS
|
Year
|
2020
|
2021
|
|---|---|---|
| Total assets | 245 460,66 | 304 383,23 |
| A. Fixed assets | 127 400,00 | 132 680,82 |
| B. Current assets | 118 060,66 | 171 702,41 |
| C. Share capital contributions (basic funds) | - | - |
| D. Own shares (stocks) | - | - |
| Total liabilities | 245 460,66 | 304 383,23 |
| A. Equity | 218 685,68 | 268 584,65 |
| B. Liabilities and provisions for liabilities | 26 774,98 | 35 798,58 |
| I. Long-term liabilities | 0,00 | - |
| II. Short-term liabilities | 21 469,98 | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.